PULMATRIX, INC. Operating Lease Cost
PULMATRIX, INC. (PULM) reported Operating Lease Cost of $678.00 thousand for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-09-17
- PULMATRIX, INC. operating lease, cost for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. operating lease, cost for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. operating lease, cost for the quarter ending 2024-06-30 was $271.00K, a 35.17% decline year-over-year.
- PULMATRIX, INC. operating lease, cost for the quarter ending 2024-03-31 was $407.00K, a 7.67% increase year-over-year.
- PULMATRIX, INC. operating lease, cost for fiscal 2023 was $1.75M, a 22.59% increase from fiscal 2022.
- PULMATRIX, INC. operating lease, cost for fiscal 2022 was $1.43M, a 25.99% increase from fiscal 2021.
- PULMATRIX, INC. operating lease, cost for fiscal 2021 was $1.14M, a 24.86% increase from fiscal 2020.
- PULMATRIX, INC. operating lease, cost for fiscal 2020 was $909.00K, a 38.99% increase from fiscal 2019.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $0.00 derived: sum of 2 quarters · filed 2026-09-17 | $271.00K derived: sum of 3 quarters · filed 2026-09-17 | $678.00K S-4/A · filed 2026-09-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $271.00K derived: sum of 2 quarters · filed 2024-11-08 | $678.00K 10-Q · filed 2024-11-08 | $1.08M derived: sum of 4 quarters · filed 2025-03-21 |
| 2024-06-30 | $271.00K 10-Q · filed 2024-08-13 | $678.00K 10-Q · filed 2024-08-13 | $1.08M derived: sum of 3 quarters · filed 2025-03-21 | $1.64M derived: sum of 4 quarters · filed 2025-03-21 |
| 2024-03-31 | $407.00K 10-Q · filed 2024-05-10 | $811.00K derived: sum of 2 quarters · filed 2025-03-21 | $1.36M derived: sum of 3 quarters · filed 2025-03-21 | $1.78M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-12-31 | $404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $957.00K derived: sum of 2 quarters · filed 2025-03-21 | $1.38M derived: sum of 3 quarters · filed 2025-03-21 | $1.75M 10-K · filed 2025-03-21 |
| 2023-09-30 | $553.00K 10-Q · filed 2024-11-08 | $971.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.35M 10-Q · filed 2024-11-08 | $1.71M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $418.00K 10-Q · filed 2024-08-13 | $796.00K 10-Q · filed 2024-08-13 | $1.15M derived: sum of 3 quarters · filed 2024-08-13 | $1.51M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $378.00K 10-Q · filed 2024-05-10 | $736.00K derived: sum of 2 quarters · filed 2024-05-10 | $1.09M derived: sum of 3 quarters · filed 2024-05-10 | $1.45M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $715.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.07M derived: sum of 3 quarters · filed 2024-03-28 | $1.43M 10-K · filed 2024-03-28 |
| 2022-09-30 | $357.00K 10-Q · filed 2023-11-09 | $714.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.07M 10-Q · filed 2023-11-09 | $1.43M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $357.00K 10-Q · filed 2023-08-10 | $715.00K 10-Q · filed 2023-08-10 | $1.07M derived: sum of 3 quarters · filed 2023-08-10 | $1.33M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $357.00K 10-Q · filed 2023-05-12 | $715.00K derived: sum of 2 quarters · filed 2023-05-12 | $974.00K derived: sum of 3 quarters · filed 2023-05-12 | $1.23M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $617.00K derived: sum of 2 quarters · filed 2023-03-30 | $876.00K derived: sum of 3 quarters · filed 2023-03-30 | $1.14M 10-K · filed 2023-03-30 |
| 2021-09-30 | $259.00K 10-Q · filed 2022-11-10 | $518.00K derived: sum of 2 quarters · filed 2022-11-10 | $777.00K 10-Q · filed 2022-11-10 | $1.04M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $259.00K 10-Q · filed 2022-08-10 | $518.00K 10-Q · filed 2022-08-10 | $777.00K derived: sum of 3 quarters · filed 2022-08-10 | $1.04M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $259.00K 10-Q · filed 2022-05-12 | $518.00K derived: sum of 2 quarters · filed 2022-05-12 | $777.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.00M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $518.00K derived: sum of 2 quarters · filed 2022-03-29 | $746.00K derived: sum of 3 quarters · filed 2022-03-29 | $909.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $259.00K 10-Q · filed 2021-11-10 | $487.00K derived: sum of 2 quarters · filed 2021-11-10 | $650.00K 10-Q · filed 2021-11-10 | $814.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $228.00K 10-Q · filed 2021-08-10 | $391.00K 10-Q · filed 2021-08-10 | $555.00K derived: sum of 3 quarters · filed 2021-08-10 | $718.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $163.00K 10-Q · filed 2021-05-11 | $327.00K derived: sum of 2 quarters · filed 2021-05-11 | $490.00K derived: sum of 3 quarters · filed 2021-05-11 | $654.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $164.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $327.00K derived: sum of 2 quarters · filed 2021-03-23 | $491.00K derived: sum of 3 quarters · filed 2021-03-23 | $654.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $163.00K 10-Q · filed 2020-11-12 | $327.00K derived: sum of 2 quarters · filed 2020-11-12 | $490.00K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $164.00K 10-Q · filed 2020-08-07 | $327.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $163.00K 10-Q · filed 2020-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |